Clinical Laserthermia Systems AB (publ)

OM:CLS UR B Rapporto sulle azioni

Cap. di mercato: SEK 22.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Clinical Laserthermia Systems Gestione

Gestione criteri di controllo 1/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Dan Mogren

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO2.6yrs
Proprietà del CEOn/a
Durata media del managementless than a year
Durata media del Consiglio di amministrazione3yrs

Aggiornamenti recenti sulla gestione

Nessun aggiornamento

Recent updates

Nessun aggiornamento

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Dan Mogren rispetto agli utili di Clinical Laserthermia Systems?
DataCompenso totaleStipendioGuadagni aziendali
Mar 31 2023n/an/a

-SEK 78m

Dec 31 2022n/an/a

-SEK 71m

Sep 30 2022n/an/a

-SEK 81m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 2mSEK 1m

-SEK 64m

Compensazione vs Mercato: Insufficient data to establish whether Dan's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensazione vs guadagni: Insufficient data to compare Dan's compensation with company performance.

AMMINISTRATORE DELEGATO

Dan Mogren

2.6yrs

Mandato

SEK 1,551,882

Compensazione

Mr. Dan J. Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief Commer...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Dan Mogren
Chief Executive Officer2.6yrsSEK 1.55mNessun dato
Lars-Erik Eriksson
Co-Founder & Directorno dataSEK 1.65mNessun dato
Rolf Bornschein
Chief Financial Officerless than a yearNessun datoNessun dato
Jimmy Johansson
Executive Vice President of Operationsless than a yearNessun datoNessun dato
Stephan Dymling
Head of Technical Developmentno dataNessun datoNessun dato
Karin Peterson
Chief Product Officerno dataNessun datoNessun dato
Mats Ekelund
Chief Medical Officerno dataNessun datoNessun dato

0.8yrs

Durata media

Gestione esperta: CLS UR B's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Lars-Erik Eriksson
Co-Founder & Director17.5yrsSEK 1.65mNessun dato
Hans von Celsing
Independent Chairman of the Board10.5yrsSEK 285.00k0.22%
SEK 48.9k
Gunilla Savring
Independent Director3.5yrsSEK 142.50kNessun dato
Rolf Kiessling
Member of Clinical Advisory Board2.1yrsSEK 80.00kNessun dato
Karl-Göran Tranberg
Member of Clinical Advisory Board2.1yrsSEK 80.00k0.90%
SEK 200.9k
Paolo Raffaelli
Independent Director2.5yrsSEK 62.50kNessun dato
Marika Crohns
Independent Director & Member of Clinical Advisory Board3.5yrsSEK 142.50kNessun dato
Sandy Brandmeier
Independent Director2.5yrsNessun datoNessun dato

3.0yrs

Durata media

67.5yo

Età media

Consiglio di amministrazione esperto: CLS UR B's board of directors are considered experienced (3 years average tenure).